...
首页> 外文期刊>Nucleic acids research >Cloning and expression of the hypoxanthine-guanine phosphoribosyltransferase gene from Trypanosoma brucei
【24h】

Cloning and expression of the hypoxanthine-guanine phosphoribosyltransferase gene from Trypanosoma brucei

机译:布氏锥虫次黄嘌呤-鸟嘌呤磷酸核糖基转移酶基因的克隆与表达

获取原文

摘要

The hypoxanthine-guanine phosphoribosyltransferase (HGPRT) enzyme of Trypanosoma brucei and related parasites provides a rational target for the treatment of African sleeping sickness and several other parasitic diseases. To characterize the T. brucei HGPRT enzyme in detail, the T. brucei hgprt was isolated within a 4.2 kb SalI-KpnI genomic insert and sequenced. Nucleotide sequence analysis revealed an open reading frame of 630 bp that encoded a protein of 210 amino acids with a Mr = 23.4 kd. After gap alignment, the T. brucei HGPRT exhibited 21 - 23 amino acid sequence identity, mostly in three clustered regions, with the HGPRTs from human, S. mansoni, and P. falciparum, indicating that the trypanosome enzyme was the most divergent of the group. Surprisingly, the T. brucei HGPRT was more homologous to the hypoxanthine phosphoribosyltransferase (HPRT) from the prokaryote V. harveyi than to the eukaryotic HGPRTs. Northern blot analysis revealed two trypanosome transcripts of 1.4 and 1.9 kb, each expressed to equivalent degrees in insect vector and mammalian forms of the parasite. The T. brucei hgprt was inserted into an expression plasmid and transformed into Sφ606 E. coli that are deficient in both HPRT and xanthine-guanine phosphoribosyltransferase activities. Soluble, enzymatically active recombinant T. brucei HGPRT was expressed to high levels and purified to homogeneity by GTP-agarose affinity chromatography. The purified recombinant enzyme recognized hypoxanthine, guanine, and allopurinol, but not xanthine or adenine, as substrates and was inhibited by a variety of nucleotide effectors. The availability of a molecular clone encoding the T. brucei hgprt and large quantities of homogeneous recombinant HGPRT enzyme provides an experimentally manipulate molecular and biochemical system for the rational design of novel therapeutic agents for the treatment of African sleeping sickness and other diseases of parasitic origin.
机译:布氏锥虫和相关寄生虫的次黄嘌呤-鸟嘌呤磷酸核糖基转移酶(HGPRT)酶为治疗非洲昏睡病和其他几种寄生虫病提供了合理的靶标。为了详细表征布鲁氏菌HGPRT酶,将布鲁氏菌hgprt分离到4.2 kb SalI-KpnI基因组插入片段中并测序。核苷酸序列分析揭示了一个630 bp的开放阅读框,该框编码210个氨基酸的蛋白,M = 23.4 kd。缺口比对后,布鲁氏杆菌HGPRT与人类,曼氏葡萄球菌和恶性疟原虫的HGPRTs表现出21-23个氨基酸序列同一性,主要在三个聚簇区域,这表明锥虫酶是最广泛的锥虫酶。组。出人意料的是,布氏锥虫HGPRT与原核V. harveyi的次黄嘌呤磷酸核糖基转移酶(HPRT)同源,而与真核HGPRT同源。 Northern印迹分析揭示了两个1.4和1.9 kb的锥虫转录本,每个在昆虫载体和哺乳动物形式的寄生虫中均表达相同的程度。将布鲁氏菌hgprt插入表达质粒中,并转化入HPRT和黄嘌呤-鸟嘌呤磷酸核糖基转移酶活性均不足的Sφ606大肠杆菌中。可溶性的,具有酶活性的重组布鲁氏菌HGPRT被高水平表达,并通过GTP-琼脂糖亲和层析纯化至均一。纯化的重组酶识别次黄嘌呤,鸟嘌呤和别嘌呤醇,但不识别黄嘌呤或腺嘌呤作为底物,并被多种核苷酸效应子抑制。编码布鲁氏菌hgprt的分子克隆和大量均质重组HGPRT酶的可用性为合理设计用于治疗非洲昏睡病和其他寄生性疾病的新型治疗剂提供了实验控制的分子和生化系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号